Patents Assigned to Ark Therapeutics Limited
  • Patent number: 7905847
    Abstract: A device which comprises an enclosure of a plastics material, having an opening at an end thereof with fastening means to enable the opening to be closed around a limb or stump with an affected part contained within the enclosure, and including a fluid-absorbent material within the enclosure. The device is particularly suitable for use in the treatment of leg ulcers.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: March 15, 2011
    Assignee: Ark Therapeutics Limited
    Inventor: Stephen George Edward Barker
  • Patent number: 7208291
    Abstract: The present invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: April 24, 2007
    Assignee: Ark Therapeutics Limited
    Inventors: Seppo Yla-Herttuala, Markku Kulomaa, Pauliina Lehtolainen, Varpu Marjomaki, Kari Airenne
  • Patent number: 7071183
    Abstract: It has been found that inhibitors of the renin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: July 4, 2006
    Assignee: Ark Therapeutics Limited
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky